Eloxx Pharmaceuticals, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
10QSB/A
10SB12G
10SB12G/A
25-NSE
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFM14A
EFFECT
FWP
NT 10-K
NT 10-K/A
NT 10-Q
NT 10-Q/A
NTN 10K
PRE 14A
PREM14A
PRER14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10SB12G/A | — | 0001012895-97-000078 | Jul 10, 1997 | — |
| 10SB12G | — | 0001012895-97-000024 | Mar 27, 1997 | — |